Doç. Dr. Seval Ay Ersoy

Prognostic Impact and Clinicopathological Correlates of HER2 Status in Gastric Cancer: A Multicenter Retrospective Turkish Oncology Group Study

Clinical Medicine Insights Oncology, 2026

DOI 10.1177/11795549261445290 PMID 42131419 Texte intégral en libre accèsSource : OpenAlex

Prognostic value of PSA Kinetic Ratio in high-volume mCSPC patients treated with abiraterone or enzalutamide: a single-center retrospective study

BMC Cancer, 2026

DOI 10.1186/s12885-026-16037-8 PMID 41987096 Texte intégral en libre accèsSource : OpenAlex

Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15010386 PMID 41517635 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma

Journal of Cancer Research and Clinical Oncology, 2026

DOI 10.1007/s00432-025-06411-7 PMID 41504775 3 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Impact of Peri-Immunotherapy Antibiotic Exposure on Survival Outcomes in Metastatic Renal Cell Carcinoma: A Real-World IMDC Risk–Stratified Analysis

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15051853 PMID 41827267 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15020553 PMID 41598493 Texte intégral en libre accèsSource : OpenAlex

Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2− Metastatic Breast Cancer: A Real-World Cohort Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15041671 PMID 41753358 Texte intégral en libre accèsSource : OpenAlex

Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature

Clinical Genitourinary Cancer, 2026

DOI 10.1016/j.clgc.2026.102594 PMID 42349378 Source : OpenAlex

Neoadjuvant Pertuzumab in Breast Cancer and Associated Prognostic Factors

European Archives of Medical Research, 2026

DOI 10.14744/eamr.2025.35682 Texte intégral en libre accèsSource : OpenAlex

Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study

Scientific Reports, 2026

DOI 10.1038/s41598-026-61625-0 PMID 42457832 Texte intégral en libre accèsSource : OpenAlex

Adding immunotherapy to chemotherapy may improve survival after SCLC transformation in EGFR-mutant NSCLC: a multicenter real-world study

Lung Cancer, 2026

DOI 10.1016/j.lungcan.2026.109590 PMID 42664544 Texte intégral en libre accèsSource : ORCID

Hormon Pozitif Her2 Negatif Meme Kanserinde Neoadjuvan ve Adjuvan Tedavi Seçenekleri

Atlas Universitesi Tip ve Saglik Bilimleri Dergisi, 2026

DOI 10.54270/atljm.2026.117 Texte intégral en libre accèsSource : ORCID

Prognostic Impact of Immune-Related Adverse Events in Patients with Non–Small Cell Lung Cancer Treated with Second-Line Nivolumab: A Single-Center Real-World Experience

Eurasian Journal of Medical Investigation, 2026

DOI 10.14744/ejmi.263046 Source : OpenAlex

Treatment Outcomes and Toxicity of Cisplatin–Etoposide-Based Regimens and Carboplatin–Paclitaxel as Adjuvant Chemotherapy for Ovarian Adult Granulosa Cell Tumors: A Multicenter Retrospective Cohort Study

Cancers, 2026

DOI 10.3390/cancers18182910 PMID 42794877 Texte intégral en libre accèsSource : OpenAlex

The Association of Khorana Risk Score with Venous Thromboembolism and Overall Survival in Patients with Metastatic Gastric Cancer

Medicina, 2025

DOI 10.3390/medicina61061075 PMID 40572762 6 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Impact of Blood Type on Treatment Response and Survival in HER2-Negative Metastatic Gastric Cancer

Cerrahpasa Medical Journal, 2025

DOI 10.5152/cjm.2025.25042 Texte intégral en libre accèsSource : OpenAlex

Triple-Negative Apocrine Carcinoma: Largest Cohort Highlights Unique Biology and Survival Advantage

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14197103 PMID 41096183 4 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

The Effect of the Clinical-Pathological CPS+EG Staging System on Survival Outcomes in Patients with HER2-Positive Breast Cancer Receiving Neoadjuvant Treatment: A Retrospective Study

Medicina, 2025

DOI 10.3390/medicina61101813 PMID 41155800 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Prognostic Impact of Tumor Size in Patients with Stage T3N1 Colon Cancer

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm15010247 PMID 41517497 Texte intégral en libre accèsSource : OpenAlex

Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine

Medicina, 2025

DOI 10.3390/medicina61050819 PMID 40428777 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Impact of Metastasectomy on Survival Outcomes in Colorectal Cancer: A Single Center Retrospective Study

Acta haematologica oncologica Turcica., 2025

DOI 10.4274/ahot.galenos.2025.2025-1-1 Texte intégral en libre accèsSource : OpenAlex

Treatment outcomes of sunitinib and/or pazopanib in advanced alveolar soft part sarcoma: A Turkish Oncology Group (TOG) study

Scientific Reports, 2025

DOI 10.1038/s41598-025-29276-9 PMID 41315659 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Prognostic impact of pan-immune-inflammation value and prognostic nutritional index in metastatic colorectal cancer patients treated with regorafenib

The European Research Journal, 2025

DOI 10.18621/eurj.1768888 Texte intégral en libre accèsSource : ORCID

Prognostic factors and the impact of adjuvant chemotherapy on recurrence and survival in stage I non-small cell lung cancer: A real-world study

The European Research Journal, 2025

DOI 10.18621/eurj.1633305 Texte intégral en libre accèsSource : ORCID

Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

Journal of Chemotherapy, 2024

DOI 10.1080/1120009x.2024.2366683 PMID 38904164 1 citation (Europe PMC) Source : OpenAlex

Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens

Oncology Letters, 2023

DOI 10.3892/ol.2023.13795 PMID 37123028 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer

Breast Care, 2023

DOI 10.1159/000526732 PMID 36876171 7 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Combining Immunotherapy with Transarterial Radioembolization.

Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India, 2023

DOI 10.4103/ijnm.ijnm_180_22 PMID 37456187 3 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?

Expert Review of Anticancer Therapy, 2022

DOI 10.1080/14737140.2022.2076670 PMID 35543015 3 citations (Europe PMC) Source : OpenAlex

The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study

Journal of Chemotherapy, 2022

DOI 10.1080/1120009x.2022.2040770 PMID 35174772 Texte intégral en libre accèsSource : OpenAlex

FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer

Journal of Chemotherapy, 2022

DOI 10.1080/1120009x.2022.2026125 PMID 35037592 15 citations (Europe PMC) Source : OpenAlex

¿Es el intervalo libre de docetaxel un factor predictivo para el cáncer de próstata resistente a la castración?

Actas Urológicas Españolas, 2022

DOI 10.1016/j.acuro.2021.10.003 Source : ORCID

Is adipose tissue metabolic activity a predictor of pathological responses to neoadjuvant treatment in breast cancer

Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2022

DOI 10.1016/j.remnie.2022.08.003 PMID 35988844 4 citations (OpenAlex) Source : OpenAlex

Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer?

Actas Urológicas Españolas (English Edition), 2022

DOI 10.1016/j.acuroe.2021.10.005 PMID 35786543 Source : OpenAlex

¿Es la actividad metabólica del tejido adiposo un predictor de respuesta histopatológica al tratamiento neoadyuvante en el cáncer de mama?

Revista Española de Medicina Nuclear e Imagen Molecular, 2022

DOI 10.1016/j.remn.2022.05.002 Source : OpenAlex

Second Line Treatment Choice in Extensive Small Lung Cancer

Eurasian Journal of Medical Investigation, 2022

DOI 10.14744/ejmi.2022.72208 Source : OpenAlex

Alveolar Soft Part Sarkomlar ve Periferik Sinir Kılıfı Tümörleri

Akademisyen Kitabevi eBooks, 2022

DOI 10.37609/akya.2239.c17320 Source : OpenAlex

Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer

Future Oncology, 2021

DOI 10.2217/fon-2021-0398 PMID 34323116 2 citations (Europe PMC) Source : OpenAlex

Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study

European Journal of Breast Health, 2021

DOI 10.4274/ejbh.galenos.2020.6346 PMID 33870111 11 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Prognostic factors of ado-trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/1078155220924088 PMID 32423326 8 citations (Europe PMC) Source : ORCID

Onkolojide Destek Tedaviler ve Semptom Yönetimi

Akademisyen Kitabevi eBooks, 2021

DOI 10.37609/akya.180 Source : OpenAlex

The role of mean platelet volume in nonalcoholic fatty liver disease without cardiovascular comorbidities, obesity and diabetes mellitus

European Journal of Gastroenterology & Hepatology, 2021

DOI 10.1097/meg.0000000000002189 PMID 34397640 2 citations (Europe PMC) Source : ORCID

Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?

Journal of Oncology Pharmacy Practice, 2021

DOI 10.1177/1078155220951612 PMID 32847482 2 citations (Europe PMC) Source : ORCID

Role of tumor location on high-grade serous ovarian cancer prognosis.

Ginekologia polska, 2021

DOI 10.5603/gp.a2021.0123 PMID 34105739 1 citation (Europe PMC) Texte intégral en libre accèsSource : ORCID

Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer

Journal of the College of Physicians and Surgeons Pakistan, 2021

DOI 10.29271/jcpsp.2021.06.651 PMID 34102775 8 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study

Clinical Interventions in Aging, 2019

DOI 10.2147/cia.s201039 PMID 30962679 25 citations (Europe PMC) Texte intégral en libre accèsSource : ORCID

Neoadjuvant treatment in patients with locally advanced gastric cancer.

Journal of Clinical Oncology, 2019

DOI 10.1200/jco.2019.37.4_suppl.127 3 citations (OpenAlex) Source : ORCID

Case report: An atypical presentation of dementia with affective disorder

DergiPark (Istanbul University), 2019

Source : OpenAlex

Associations between metabolic syndrome and osteoporosis in elderly with chronic thyroiditis treated with thyroid hormone

Clinical Nutrition, 2018

DOI 10.1016/j.clnu.2018.06.1940 Source : OpenAlex

Kronik böbrek hastalarında intravenöz demir tedavisi, oksidatif stres ve N-asetilsistein'in etkisi

Turkish Journal of Nephrology, 2011

Source : OpenAlex